July 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas
Contract Categories:
Human Resources
- Retention Agreements
EX-10.6 7 exhibit106-july2023amendme.htm EX-10.6 Document
| Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. | ||
Exhibit 10.6
[Akebia Letterhead]
July 26, 2023
By Email
Nicole R. Hadas
[Address]
Dear Nikki:
Upon your execution of this Amendment, the following amendments will be made to your Separation Agreement with Akebia Therapeutics, Inc. (“Akebia”) dated May 5, 2022 (as previously amended, the “Separation Agreement”)
A.Paragraph 1(ii) of the Separation Agreement shall be replaced in its entirety with the following:
(ii) Separation Date. Unless your employment is terminated by the Company for Cause or by you for Good Reason (as those terms are defined in your Executive Severance Agreement dated March 3, 2014, the “ESA”), you will remain employed until October 6, 2023; unless, [**], but in any event no later than March 22, 2024 (as applicable, the “Separation Date”). The Separation Date may be modified only upon mutual agreement between you and the Company.
All other terms and conditions of the Separation Agreement shall remain in full force and effect.
Very truly yours,
AKEBIA THERAPEUTICS, INC.
/s/ John P. Butler
John P. Butler
President and Chief Executive Officer
Accepted and Agreed to Under Seal:
/s/ Nicole R. Hadas
Nicole R. Hadas
Dated: July 27 , 2023
